Physician profile
Phyllis L Townsend
NPI 1366505844
$492.30
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $57.04 · 2021: $55.08 · 2022: $72.47 · 2023: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $127.19 | 2022-2023 | |
| Neos Therapeutics, LP | $77.64 | 2019 | |
| Sanofi Pasteur INC. | $64.83 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.77 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $43.59 | 2021-2022 | |
| Tris Pharma INC | $34.22 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $19.67 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.88 | 2019 | |
| Ironshore Pharmaceuticals INC. | $17.08 | 2019 | |
| Pfizer INC. | $14.07 | 2020 | |
| Kaleo, INC. | $13.01 | 2019 | |
| Adlon Therapeutics L.P. | $11.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phyllis Townsend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.